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Ghrelin is a peptidic hormone, which stimulates cell proliferation and inhibits apoptosis in several tissues, including pancreas. In
preclinical stage of type 1 diabetes, proinflammatory cytokines generate a destructive environment for 𝛽-cells known as insulitis,
which results in loss of 𝛽-cell mass and impaired insulin secretion, leading to diabetes. Our aim was to demonstrate that ghrelin
could preserve 𝛽-cell viability, turnover rate, and insulin secretion acting as a counter balance of cytokines. In the present work
we reproduced proinflammatory milieu found in insulitis stage by treating murine cell line INS-1E and rat islets with a cytokine
cocktail including IL-1𝛽, IFN𝛾, and TNF𝛼 and/or ghrelin. Several proteins involved in survival pathways (ERK 1/2 and Akt/PKB)
and apoptosis (caspases and Bcl-2 protein family and endoplasmic reticulum stress markers) as well as insulin secretion were
analyzed. Our results show that ghrelin alone has no remarkable effects on 𝛽-cells in basal conditions, but interestingly it activates
cell survival pathways, downregulates apoptotic mediators and endoplasmic reticulum stress, and restores insulin secretion in
response to glucose when beta-cells are cytokine-exposed. These data suggest a potential role of ghrelin in preventing or slowing
down the transition from a preclinical to clinically established diabetes by ameliorating the effects of insulitis on 𝛽-cells.
1. Introduction
Ghrelin, a 28-amino acid peptidic hormone, is the endoge-
nous ligand of the orphan receptor of growth hormone
secretagogues (GHS-R). Its main functions are the stimula-
tion of GH secretion by the pituitary somatotrophs [1] and
appetite upregulation by inducing neuropeptide Y (NPY)
production at the hypothalamus [2]. Besides, ghrelin regu-
lates metabolism and energy balance at several levels [3].
Type 1 diabetes mellitus is an autoimmune disease in
which pancreatic 𝛽-cells are specifically damaged—among
other mechanisms—by apoptosis [4, 5]. Before the clinical
onset of the disease, an inflammatory lesion known as
insulitis develops due to the recruitment of macrophages
and CD8+ T lymphocytes to the islets and the release of
several soluble mediators and cytokines, mainly IFN-𝛾, TNF-
𝛼, and IL-1𝛽, causing𝛽-cells apoptosis [6].This inflammatory
microenvironment observed in pancreatic islets during type 1
diabetes can be mimicked by adding these cytokines to 𝛽-cell
cultures.
Two main apoptotic pathways have been described: the
intrinsic and the extrinsic pathways; both interconnected
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at several levels and both are activated by proinflammatory
cytokines in pancreatic 𝛽-cells [7–9]. Endoplasmic reticulum
(ER) stress-induced apoptosis has also been involved in
cytokine toxicity to 𝛽-cells and cell lines, although it has not
proven essential for the detrimental effects of cytokines [10–
14]. In ER stress response, phosphorylation of the translation
initiation factor EIF2A by EIF2AK3 is related with increased
transcription of molecular chaperones such as HSPA4 and
HSPA5 in an effort to prevent unfolded protein accumulation.
The mitochondrial pathway of apoptosis is inhibited by the
activation of some of the members of the Bcl family such as
Bcl-2𝛼 and Bcl-xL, by preventing the release of proapoptotic
mitochondrial factors [9]. Gene and protein expression of
Bcl-2 related proteins have been studied in response to
proinflammatory cytokines. Although results are identical for
some of this protein family members such as Bid and Bcl-xL,
contradictory results have been reported for others like Bcl-
2; while Mehmeti et al. report a downregulation in its gene
expression in response to cytokines, Kutlu et al. found that
its levels were maintained in identical conditions. Bad gene
expression also shows opposite results in these studies [15, 16].
Ghrelin’s effects on𝛽-cell proliferation and apoptosis have
been extensively documented both “in vitro” and “in vivo”
diabetes models. Ghrelin promotes proliferation and survival
in insulin producing cell lines and “ex vivo” cultured human
islets in presence of proinflammatory cytokines [17]. In the
same line, ghrelin treatment recovers functional 𝛽-cell mass
in pancreatectomized [18] or streptozotocin treated animals
[19–21]. However, it has not been shown whether ghrelin
has any effect on 𝛽-cells’ insulin secretion in the presence of
proinflammatory cytokines, which are well known to inhibit
their insulin production in response to glucose [22].
The aim of this study is to elucidate how ghrelin acts
on the apoptotic cascades to exert its protective effect on
cytokine treated 𝛽-cell and if it restores 𝛽-cell function
hindered by cytokine exposure. To this end, we reproduced
an in vitromodel of early insulitis in 𝛽-cells by using INS-1E
[23] and Wistar rat islets cultured in the absence or presence
of ghrelin and/or a cytokine cocktail,mimicking the cytotoxic
conditions of pancreatic islets during early insulitis.
2. Materials and Methods
2.1. Cell Culture Materials. A well-established insulinoma
cell line, INS-1E [23], was used in all in vitro experiments
described below. INS-1E cells were routinely cultured in
RPMI 1640 supplemented with 10% FBS, 1% Penicillin-
Streptomycin, 1mM sodium pyruvate (all from Gibco,
Thermo Fisher Scientific, Cheshire, UK), 10mM Hepes
buffer in 0.85% NaCl (Lonza, Barcelona, Spain), 0.05mM
𝛽-mercaptoethanol (Sigma-Aldrich), and 11mM D-glucose
(Merck,Darmstadt, Germany). For immunoblotting andflow
cytometry experiments, 3 × 105 cells were plated on 6-well
dishes and were cultured until they reached 90% confluence.
To analyze the effects of cytokines, cell cultures were
treated with a cytokine cocktail (100 ng/ml rat IFN-𝛾,
50 ng/ml rat TNF-𝛼, and 0.05 ng/ml recombinant human IL1-
𝛽, all from Peprotech, Inc., London, UK) mimicking the
cytotoxic conditions of preclinical diabetes. The cytokine
treatment period was 15, 30, and 60min for the ERK and
AKT activation test and 48 h for cell viability study, Bcl-2
related protein expression quantification, ER stress, and the
Glucose Stimulated Insulin Secretion (GSIS) determination.
The effects of this cocktail have been previously described in
cell cultures of pancreatic islets [24, 25].
To evaluate whether ghrelin reverses the deleterious
effects of cytokines, 100 nM rat acylated ghrelin (Bachem
AG, Bubendorf, Switzerland) was added to culture media
alone and together with the cytokine cocktail. Ghrelin was
renovated every 24 h. Ghrelin concentration was optimized
previously in dose response experiments using INS-1E cells.
2.2. Trypan Blue Exclusion Test of Cell Viability. Dye exclu-
sion tests are used to determine the rate of viable cells
present in a cell suspension, based on the principle that live
cells with intact cell membranes will exclude dyes, whereas
dead cells will not. When our cell cultures in all different
experimental conditions had reached a confluence of 90%,
cell were collected and 10 microlitres of the suspension
were mixed with the same volume of 0.2% trypan blue and
then visually examined under an optical microscope on a
Neubauer chamber to quantify viable cells.
2.3. MTT Assay. 30000 cells/well were cultured in a 96-well
plate at 37∘C, 5% CO
2
. After 24 h, cultures were treated with
different experimental conditions: control, cytokines, ghrelin
100mM, and a mixture of cytokines and ghrelin during 48 h.
Ghrelin was refreshed each 24 h. Culture supernatants were
eliminated and 25𝜇l of MTT solution diluted at 5mg/mL
(Merck Chemicals Limited, Darmstandt, Germany), was
added to each well. Samples were incubated 90 minutes at
37∘C with 5% CO
2
and then washed with warm PBS. PBS
was discarded and 100 𝜇l of DMSO/well was added. Plate
was covered and gently shaked during 20 minutes at RT.
Absorbance was measure at 570 nm.
2.4. Apoptosis Detection and Quantification. The rate of
apoptosis was quantified by DeadEnd Fluorometric TUNEL
System (TdT-mediated dUTP Nick-End Labeling) (Promega
Corp., Madison, WI, USA) following the manufacturer’s
instructions. Briefly, samples were permeabilized with 0.2%
Triton X-100/PBS for 20min at RT, washed with PBS, and
blocked with 4% FBS (Gibco) for 30min. The samples were
then equilibrated and incubated with the nucleotide mixture
and the enzyme for 1 h at 37∘C. The reaction was stopped
with 2% SCC for 15min at RT and then washed with water
to eliminate fluorescein-12-dUTP excess. The results are
expressed as the number of TUNEL-positive/total cells.
2.5. Isolation and Culture of Rat Islets. Pancreatic islets were
isolated from adult male Wistar rats as described previ-
ously [26]. Islets were cultured in RPMI medium (Sigma-
Aldrich, St. Louis, MO, USA) supplemented with 2mM L-
glutamine (Gibco Invitrogen, Carlsbad, CA, USA), 100U/ml
penicillin, 100 𝜇g/ml streptomycin (Pen-Strep; Bio-Whittaker
Europe, Verviers, Belgium), 10% fetal bovine serum (FBS,
Gibco Invitrogen, Carlsbad, CA, USA), and 5.5mM glucose.
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Table 1: Primer sets used in real-time quantitative PCR determinations.
Gene
symbol Alias/common name Primer sequence (5
󸀠-nyt-3󸀠) Productsize (bp)
Annealing
temperature
(∘C)
HSPA4 Hsp70, Heat Shock 70KDa protein 4 (a molecularchaperone involved in ER stress response)
F-AGCAAGCGCTCTCGGTTGCAG 133 60
R-AGACAGGACACGGACCCCCG
HSPA5 Bip, Heat Shock 70KDa protein 5 (a molecularchaperone involved in ER stress response)
F-TGCTGCTGCCCAACTGGCTG 160 60
R-GAACACGCCGACGCAGGAGT
EIF2A Eukaryotic translation initiation factor 2A F-ACGCCGCTCTTGACAGTCCG 152 60
R-TTGCCCCAGGCAAACAAGGTCC
EIF2AK3 Eukaryotic translation initiation factor 2 alphakinase 3
F-CCCCAACAAGGCCAGCCTGG 168 60
R-GGACAGCCAGCCGTGTTCCC
Proinflammatory cytokines and ghrelinwere used at the same
concentrations described above.
2.6. Analysis of Glucose-Stimulated Insulin Secretion. To study
the in vitro effect of ghrelin and/or cytokines on insulin
secretion, INS-1E cells or isolated rat islets were cultured in
5.5mM glucose medium for 24 h, to reduce basal insulin
secretion. Subsequently, ghrelin with or without cytokines
was added to culture media. Cells were then washed three
times with low glucose (2.2mM)HBSS/Krebs buffer (HBBS),
and supernatants collected to determine basal insulin secre-
tion. Afterwards, a high glucose concentration (22mM)
HBBS was added to cultures, and cells were incubated for
90min. Supernatants were collected again to measure levels
of glucose-induced insulin secretion.
Supernatants’ insulin levels were determined using a
commercially available Ultrasensitive Rat Insulin ELISA kit
(Mercodia AB, Uppsala, Sweden) following manufacturer’s
instructions.
2.7. Immunoblotting. To determine the involvement of sev-
eral proteins of the intrinsic and extrinsic apoptotic pathways
in the response of INS-1E cells to ghrelin, cytokines, or
both, western blot analysis was performed. First, cells were
collected and centrifuged and pellets were homogenized
in lysis buffer pH 6.8 (125mM Tris, 2% SDS, 1mM DTT,
and Orthovanadate [1 : 100] containing the protease inhibitor
cocktail) and supernatants protein concentration was mea-
sured using a Micro BCA kit (Thermo Fisher Scientific)
following the manufacturer’s instructions.
Protein samples (40 𝜇g) were loaded, electrophoresed on
10–15% SDS-PAGE, and transferred onto PVDF membranes
(Immobilon-P, Millipore, EEUU). They were then blocked
for 90min at RT with 0.1% Tween-20, 5% (w/v) BSA/PBS.
Afterwards, they were incubated overnight at 4∘C with the
primary antibodies for caspase-9 [1 : 1000] (Medical & Bio-
logical Laboratories Co., Naka-Ku Nagoya, Japan); caspase-
8 [1 : 1000], Bax [1 : 1000] or Bcl-xL [1 : 1000] (Thermo Fisher
Scientific), Bid [1 : 1000] (Abcam); Bcl-2 [1 : 1000] (Santa
Cruz Biotechnology Inc., Heidelberg, Germany); phospho-
Akt (Thr 308) [1 : 1000] and Akt [1 : 1000]; and phospho-ERK
1/2 [1 : 1000] andERK 1/2 [1 : 1000] (Cell Signaling Technology
Inc., Danvers, MA). Membranes were reprobed using a 𝛽-
actin antibody [1 : 2000] (Abcam), as a loading control.
Membranes were subsequently washed for 3 times in
0.1% Tween-20/PBS and incubated with the corresponding
secondary antibody conjugated with peroxidase [1 : 2000]
in 0.1% Tween-20, 5% BSA-PBS, anti-rabbit IgG (Sigma-
Aldrich, EEUU), and anti-mouse IgG (Sigma-Aldrich,
EEUU), during 60min at RT. Bound peroxidase activity
was visualized by the enhanced chemiluminescence kit
Immun-Star WesternC (BIO-RAD, EEUU) and quantified
by densitometry using the analyzer Chemidoc XRS (BIO-
RAD, EEUU) and Image J software (NIH, EEUU). Results
were normalized to control values on each membrane.
2.8. Real-Time Reverse Transcription. Total RNA was iso-
lated from INS-1E cells using the NucleoSpin RNA II Kit
(Macherey-Nagel) followed by DNase treatment. cDNA was
synthesized using the Transcriptor First Strand cDNA Syn-
thesis kit (Roche). The real-time quantitative PCR reaction
was performed from cDNA using SensiFAST SYBR No-
ROX Kit (Bioline) according to the manufacturer’s proto-
col (Bioline). The primer sets used are shown in Table 1.
Amplification conditions were initial denaturation at 95∘C
for 3min, final denaturation at 95∘C for 15 s, annealing at
60∘C for 20 s, and extension at 72∘C for 20 s for 34 cycles,
followed by melting curve analysis at temperature range of
60∘C–90∘C. Real-time data was acquired using Rotor-Gene
6000 (Corbett Research) real-time PCR detection system
and analyzed using ΔΔCt method, with mRNA expression
normalized.
2.9. Statistical Analysis. Results are presented as means +
SEM of measurements performed in at least 4 independent
experiments. Statistical comparisons were performed by
Mann-Whitney test. Statistical significance was considered
when 𝑝 value was ≤0.05.
3. Results
3.1. Ghrelin Reduces Proinflammatory Cytokine Mediated
Alterations of Survival Pathways in INS-1 Cells. Firstly we
tested if, in our model, we reproduced ghrelin’s well-known
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Figure 1: Ghrelin and cytokines’ effects on cell survival and its survival pathways. Trypan blue exclusion test of cell viability (a),MTT assay for
cell viability (b), and TUNEL-positive cells quantification to determine ghrelin’s effects on apoptosis-mediated cellular death (c). Cells were
incubated for 48 h in the absence or presence of cytokines, ghrelin, or both. (d) shows representative photomicrographs of control, cytokines
(CTK), ghrelin (GHR), and cytokines + ghrelin (CTK + GHR), ∗𝑝 < 0.05 between groups.
effects on cell viability. To this end, we quantified viable cells
in every culture condition at the time of collection of the
samples by the trypan blue exclusion test and also performed
an MTT assay. Cell viability was significantly reduced by
the cytokine cocktail used in these experiments compared
to control and ghrelin-treated cultures. When ghrelin was
added together with cytokines, it significantly recovered INS-
1E cells’ viability (Figures 1(a) and 1(b)).
We then confirmed whether, as previously described,
ghrelin would prevent cytokine-induced apoptosis in our cell
line. In the first place, we performed aDeadEnd Fluorometric
TUNEL assay which specifically detects DNA fragmentation
resulting from apoptotic signaling cascades. The cytokine
cocktail significantly increased INS-1E cell death after 48 h
(Figure 1(c)) compared to controls and this effect was impor-
tantly reduced by incubation with ghrelin.The quantification
of the number of TUNEL-positive cells versus total cells for
each experimental condition showed that while cytokines
increased apoptosis by 6-fold, coadministration of ghrelin
reduced this percentage to nearly 50%.
Akt/PKB is well known to be a key signaling protein in
several cell pathways promoting survival, being frequently
inactivated in response to a variety of stress stimuli [27].
Therefore, levels of Akt activation were investigated in our
experimental model. Cytokine-treated cultures showed a
significant reduction of phosphorylated Akt reaching its
lowest at 30min (Figures 2(a), 2(c), and 2(e)) compared to
control or ghrelin-treated cultures. However, administration
of ghrelin in addition to cytokines recovered Akt activation
at 30min, suggesting that ghrelin enhances the survival
pathways promoted by Akt.
MAPK/ERK is another signaling pathway involved in
proliferation and survival of pancreatic beta cells. To test if
ghrelin modulates the effect of proinflammatory cytokines
on ERK 1/2 activation, we examined phosphorylated ERK
1/2 levels by immunoblotting in each experimental condition.
The results showed that cytokines reduced levels of active
ERK 1/2 at 15, 30, and 60min, while ghrelin significantly
increased them at 15 and 30min, compared to controls
(Figures 2(b), 2(d), and 2(f)). Cell cultures receiving both
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Figure 2: Western blot for phosphorylated AKT (a, c, and e) and ERK 1/2 (b, d, and f). Immunoblotting was performed to quantify
phosphorylation level or AKT an ERK 1/2 treated with proinflammatory cytokines during 15 (a and d), 30 (b and e), and 60min (c and
f) alone or in presence of ghrelin. Panels below the graph show representative images of immunoblots. Results are expressed as mean ± SEM
of phosphorylated to total protein ratio and referred to control cultures (c). Values were obtained from 4 independent experiments. *𝑝 < 0.05
between groups. C, control; CTK, cytokines; GHR, ghrelin; CTK + GHR, cytokines + ghrelin.
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cytokines and ghrelin showed activation levels similar to con-
trols and significantly higher than those of cytokine-treated
cultures, suggesting that ghrelin counteracts the toxicity of
proinflammatory cytokines by inducing ERK 1/2 activation.
3.2. Ghrelin Restores ApoptoticMachinery Close to Basal Levels
in Proinflammatory Cytokines Treated INS-1 Cells. To explore
the cellular mechanisms involving ghrelin effects on proin-
flammatory cytokine mediated apoptosis of INS-1E cells,
immunoblotting was performed to evaluate the upstream
proteins involved in the intrinsic and extrinsic pathways
of apoptosis, that is, caspase-9 and caspase-8, respectively.
As previously reported, cytokine treatment induces caspase-
8 and caspase-9 activation and ghrelin administration sig-
nificantly prevented this effect in the case of caspase-8
(Figures 3(a) and 3(b)), suggesting that ghrelin inhibits the
activation of the extrinsic pathway of apoptosis triggered by
proinflammatory cytokines, probably upstream of caspase-8.
Furthermore, we analyzed the levels of several proteins
of the Bcl-2 family. First, we studied the levels of the
proapoptotic proteins BID and Bax. In our experimental
model, cytokines significantly increased BID and Bax levels
in INS-1E cells (Figures 3(c) and 3(d), resp.), and the addition
of ghrelin to culture media prevented this effect.
Next, levels of the prosurvival members of the Bcl-2
family, Bcl-xL and Bcl-2𝛼, were explored. Interestingly, the
levels of Bcl-2𝛼 were also significantly increased in response
to cytokine exposure compared to controls (Figure 3(e)).
Ghrelin administration did not induce Bcl-2𝛼 upregulation,
but when cells received ghrelin together with proinflam-
matory cytokines, the effect of the latter on Bcl-2𝛼 was
completely attenuated, reaching control levels. Bcl-xL levels
however did not significantly vary among different experi-
mental conditions (Figure 3(f)).
3.3. Ghrelin Reduces Cytokines Mediated ER Stress Response
Activation. To study effect of ghrelin in cytokines mediated
ER stress response on INS-1 cells, gene expression of ER
stress markers were determined. EIF2AK3 is an initiator
of ER stress process and its expression is increased in
response to cytokines. Ghrelin addition to cytokines treated
cultures restores EIF2AK3 expression (Figure 4(a)). EIF2A,
(EIF2AK3’s substrate), slightly decreases its expression in
response to cytokines and ghrelin treatment restores its
level to control levels (Figure 4(b)). HSPA4 and HSPA5
chaperones expression was also quantified in response to
cytokines alone or in combination with ghrelin and a 3-
fold increase was observed with the addition of cytokines in
HSPA4mRNA expression (Figures 4(c) and 4(d)).This effect
was reverted by ghrelin addition to cultures.
3.4. Ghrelin Recovers the Ability of 𝛽-Cells to Secrete Insulin
in Response to Glucose Challenge under Cytotoxic Conditions.
INS-1E cells responded to the glucose overload challenge
secreting insulin as expected, while the cytokine cocktail
mimicking the proinflammatory condition of 𝛽-cells in a
diabetic pancreas severely decreased their ability to pro-
duce insulin (Figure 5(a)). Importantly, ghrelin treatment
of cytokines exposed cells recovered insulin secretion in
response to glucose overload was by almost 75% compared
to controls, suggesting that ghrelin could improve 𝛽-cell
function during insulitis. Cultured rat islets exhibited a
pattern of insulin secretion in response to glucose very
similar to that of INS-1E cells in response to cytokines
and ghrelin partially prevented this deleterious effect also
(Figure 5(b)).
4. Discussion
Thepresent study highlights the potential of ghrelin to protect
pancreatic 𝛽-cells from cytokine-induced toxicity during
insulitis, by activating survival pathways and by inhibiting
the apoptosis machinery. A consequence of the molecular
mechanisms promoted by ghrelin is the preservation of 𝛽-
cell’s insulin secretion in response to glucose when cultured
with proinflammatory cytokines.
Cytokines are known to lead to important transcriptional
and translational modifications both in INS-1 and INS-1E
cells and in rat pancreatic islets thatmay eventually contribute
to 𝛽-cell dysfunction and to cell death [16, 28–30]. Among
these altered proteins, there are several involved in insulin
secretion and in cell defense against endoplasmic reticulum
and oxidative stress.
We reproduced in our model ghrelin’s well-known bene-
ficial effects on cell viability and then analyzed some signal-
ing molecules involved in 𝛽-cell proliferation and survival.
Levels of activated ERK 1/2 decreased at 15 and 30min of
cytokine exposure, explaining the decrease in cell prolifera-
tion previously reported by our group [24]. The same effect
was observed when analyzing Akt/PKB activation levels;
cytokines significantly decreasedAkt/PKB activation levels at
30min. This event which is in accordance with data from Li
et al. [31] could be responsible for the reduced 𝛽-cell survival
previously reported [17] in response to cytokines.
In our hands, ghrelin addition to cytokine-exposed 𝛽-
cells completely reversed cytokine effects on ERK 1/2 acti-
vation at 15 and 30min. A similar effect was reported in
Doxorubicin-mediated apoptosis in HIT-T15 𝛽-cell line [32].
In addition, ghrelin totally recovered phospho-Akt levels
impaired by cytokines. These molecular events could be
underlying the known effects of ghrelin on 𝛽-cell survival in
cytotoxic models [17].
Cytokines are known to trigger 𝛽-cell apoptosis by
two main mechanisms: activating proapoptotic signaling
pathways, such as NF𝜅B [33], and promoting the activity
of inducible nitric oxide synthase (iNOS) [34]. Thus, we
confirmed that cytokines induced apoptosis in our model
and this effect occurred by caspase-8 and caspase-9 acti-
vation, triggering both the extrinsic and intrinsic pathways
of apoptosis as previously described by others [8, 35, 36].
Ghrelin addition recovered this effect by inhibiting caspase-8
activation. Absence of caspase-9 activation reversion suggests
a downstream effect of ghrelin on intrinsic pathway.
In addition, when analyzing the mitochondrial pathway
of apoptosis, in which the Bcl-2 protein family is involved,
we observed the activation of the proapoptotic “BH3-only”
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Figure 3: Ghrelin and cytokines’ effects on levels of caspases and Bcl-2 protein family members. Immunoblotting was performed to measure
relative mean levels of active caspase-8 (a); active caspase-9 (b); BID (c); Bax (d); Bcl-2 (e); and Bcl-xL (f). Panels below the graphs show
representative images of studied protein immunoblots. Results are presented as mean ± SEM of actin/studied protein ratio and referred to
control cultures (c). Values were obtained from 4 independent experiments. *𝑝 < 0.05 between groups. C, control; CTK, cytokines; GHR,
ghrelin; CTK + GHR, cytokines + ghrelin.
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Figure 4: Ghrelin and cytokines’ effects on ER stress response markers. Real-time quantitative PCR reaction was performed to measure gene
levels of EIF2AK3 (a), EIF2A (b), HSPA4 (c), andHSPA5 (d) in cytokines treated cultures alone or in presence of ghrelin. Results are presented
as mean ± SEM of mRNA expression indicated as arbitrary units. Values were obtained from 4 independent experiments. *𝑝 < 0.05 between
groups. C, control; CTK, cytokines; GHR, ghrelin; CTK + GHR, cytokines + ghrelin.
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Figure 5: Ghrelin and cytokines’ effects on insulin secretion. Glucose stimulated insulin secretion (GSIS) by INS-1 (a) and rat islet (b) cultures
incubated in absence (C, control) or presence of cytokines (CTK), ghrelin (GHR), or both (CTK + GHR) for 48 h. Values are expressed as
the ratio of insulin secreted at a stimulatory glucose concentration (22mM) to insulin secreted at a basal glucose concentration (5.5mM) and
represent means ± SEM of values from 4 independent experiments. *𝑝 < 0.05; **𝑝 < 0.01 between groups.
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member Bid, as well as the multidomain member Bax in
response to cytokines. Bid and Bax may act as the interme-
diaries between extrinsic and intrinsic apoptosis pathways.
Indeed, we found an upregulation of the whole pathway,
justifying the increased levels of active caspase-3 reported
by others [17]. These data are in accordance with an analysis
of the gene networks affected by cytokine treatment in INS-
1E cells [16]. We found that ghrelin was capable of restoring
this pathway to control levels, protecting INS-1E cells against
apoptotic cell death, as other authors have reported in
different cell lines [17, 32, 37].
We also studied the levels of the antiapoptotic members
of Bcl-2 protein family, that is, Bcl-2𝛼 and Bcl-XL. We
observed no differences in Bcl-XL protein levels in any of
the experimental conditions. Surprisingly, Bcl-2𝛼 protein
levels show a significant increment in response to cytokine
treatment.This observedBcl-2 increment could be a compen-
satory mechanism to counteract apoptotic stimulus. These
findings are not in accordance with those described by
Mehmeti et al. although this difference could be explained
by the experimental designs (different cell lines and time of
cytokines exposure) [15]. In contrast, the coadministration of
ghrelin to these cultures normalized Bcl-2𝛼 levels to those
found in control conditions, confirming that this hormone
interferes with proapoptotic mechanisms and promotes cell
survival in our experimental system [17, 38].
Another pathway implicated in proinflammatory cytok-
ine induced beta cell apoptosis is the ER stress response. In
INS-1 cells, ghrelin role in ER stress response modulation
has been studied by determining gene expression levels of
ER stress markers such us EIF2AK3, EIF2A, HSPA4, and
HSPA5. Cytokines induce an increment of EIF2AK3 and
HSPA4 expression (Figures 3(a) and 3(c)), while ghrelin
prevents this effect, suggesting that ghrelin participates also
in the regulation of ER stress response. The absence of
cytokine effect in EIF2A gene expression could be because its
regulation is mainly by phosphorylation [39].
It is important to highlight that ghrelin has shown no
effect on basal activation of ERK, Akt, or caspases at the doses
used. This issue is crucial when considering the safety, when
considering a potential use of ghrelin in 𝛽-cell preservation
strategies.
Finally, we would like to pinpoint that ghrelin did not
affect insulin secretion in this cell line in basal conditions, in
accordance with in vivo models [40], and most importantly,
it recovered INS-1E cells’ ability to secrete insulin in response
to glucose under cytotoxic conditions. These results were
confirmed in rat islets primary cultures, suggesting that
ghrelin treatment could improve glucose homeostasis during
the insulitis phase of diabetes development. Some authors
have described an in vivo negative effect of ghrelin on
insulin secretion; however these studies used higher doses
of the hormone [41–44]. Nevertheless, several authors have
demonstrated that ghrelin may restore glucose homeosta-
sis following streptozotocin 𝛽-cell injury [45]. Our data
encourage studying the in vivo mechanisms of ghrelin in
the pancreas regarding apoptosis, cell proliferation, and
insulin secretion in animal models of autoimmune diabetes
mellitus.
5. Conclusions
Our results show that ghrelin alone does not affect any of
the parameters we have analyzed in relation to survival and
apoptosis or glucose homeostasis as compared to controls,
suggesting that it does not affect basal 𝛽-cell turnover and
strengthening the idea that its therapeutic use would be safe
regarding these functions.
Moreover, ghrelin restores proinflammatory cytokines
induced alteration of several proteins involved in 𝛽-cell
apoptosis and survival pathways and increases the ability of
both INS-1E cells and islets in primary culture to secrete
insulin in response to glucose under cytotoxic conditions.
Taken together, our data support a potential therapeutic use
of ghrelin as a 𝛽-cell mass and function preserving factor
under cytotoxic conditions.
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